Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
The efficacy of a novel triazole, SCH51048, was assessed with a murine model of pulmonary aspergillosis and was compared with those of SCH39304 and itraconazole. A wide range of doses of SCH51048 (5 to 50 mg/kg of body weight) was evaluated. Mortality was significantly delayed in mice treated with d...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1995
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574528/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1345 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|